The bioinformatics and sequencing firm, formerly known as WuXi NextCode, will develop a population clinicogenomic database to support Emory's research.
The company also announced John Leite, the former leader of clinical business development activities at Illumina, had joined the firm as chief business officer.
University spinout PercayAI will analyze genomic and clinical data from WUSTL's McDonnell Genome Institute in search of potential coronavirus drug combinations.
The Swiss-American bioinformatics company touts its networks of multimodal data and numerous partnerships as it looks to support "data-driven medicine."
The company recently received FDA Emergency Use Authorization for its SARS-CoV-2 PCR test while its data-driven COVID-19 research initiative is moving along.
